Boston Scientific Completes Acquisition ... ( NATICK Mass. and SAN DIEGO May 28...)

Boston Scientific Completes Acquisition of CryoCor

Date:5/28/2008

NATICK, Mass. and SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (Nasdaq: CRYO) today announced that Boston Scientific has completed its acquisition of CryoCor. The transaction follows the definitive agreement announced on April 16. Under the terms of the transaction, all remaining outstanding CryoCor shares are entitled to receive $1.35 per share in cash, for a total of approximately $17.6 million. CryoCor is now an indirect, wholly-owned subsidiary of Boston Scientific.

About Boston Scientific Corporation

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Boston Scientific's Electrophysiology business is a leader in cardiac ablation products designed to treat common cardiac arrhythmias. Its line of Blazer(TM), Blazer XP(TM) and Chilli II(TM) products are used to treat arrhythmias such as Atrial Flutter and Ventricular Tachycardia. The Electrophysiology business also supplies a complete line of multi-electrode diagnostic catheters, ultrasound (ICE) catheters and accessories.

About CryoCor, Inc.

CryoCor is a medical technology company that has developed and manufactures a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System
2. Boston Scientific Announces FDA Approval of New Heart Failure Lead
3. Boston Scientifics SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R)
4. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
5. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
6. WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
7. Fraunhofer and Boston University Hosted Prestigious SME Tour
8. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
9. Boston Scientific Announces Results for First Quarter Ended March 31, 2008
10. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
11. Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System

Post Your Comments:

Boston Scientific Completes Acquisition ...( NATICK Mass. and SAN DIEGO May 28...)